US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Seaport Therapeutics

18.15

+0.24001.34%

Post-market: 18.150.00000.00%16:10 EDT

Volume:171.21K

Turnover:3.11M

Market Cap:971.58M

PE:-7.21

High:18.79

Open:18.00

Low:17.89

Close:17.91

52wk High:28.38

52wk Low:14.85

Shares:53.53M

Float Shares:14.16M

Volume Ratio:0.78

T/O Rate:1.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5160

EPS(LYR):-10.0430

ROE:-28.08%

ROA:-18.90%

PB:2.30

PE(LYR):-1.81

Loading ...

Overview Company News Filings

Seaport Therapeutics announces Phase 1 Trial of GlyphAllo met primary endpoint

Seaport Therapeutics Says Phase 1 Trial Shows GlyphAllo 375 Mg Does not Impair Next-Morning Driving vs Placebo

Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of Glyphallo™ in Healthy Volunteers

THOMSON REUTERS

Seaport Therapeutics - Key Secondary Endpoint Met for 250 Mg Glyphallo on Day 2

THOMSON REUTERS

Seaport Therapeutics - Enrolling Buoy-1 Phase 2B Trial for Glyphallo; Topline Data Expected First Half 2027

THOMSON REUTERS

Seaport Therapeutics - Glyphallo Well-Tolerated with no Serious Adverse Events Reported

THOMSON REUTERS

Seaport Therapeutics - Phase 1 Trial Meets Primary Endpoint for 375 Mg Glyphallo on Day 5

THOMSON REUTERS

Seaport Therapeutics Participates in Citi Biopharma Back to School Conference Fireside Chat

Seaport Therapeutics Initiated at Buy by Jones Trading

JonesTrading Initiates Coverage on Seaport Therapeutics With Buy Rating, $32 Price Target

MT Newswires Live

Wall Street Analysts Are Bullish on Top NA Picks

Seaport Therapeutics Price Target Maintained with a $50.00/Share by HC Wainwright & Co.

Seaport Therapeutics Price Target Maintained with a $50.00/Share by HC Wainwright & Co.

Earnings Flash (SPTX) Seaport Therapeutics Posts Q2 Loss $1.78 a Share

MT Newswires Live

Seaport Therapeutics Q2 EPS $(1.78) Misses $(0.65) Estimate

Benzinga Earnings

Seaport Therapeutics Q2 FY26 Net Loss Widens to $62.6 Million; R&D Expenses Rise to $24.62 Million

Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

THOMSON REUTERS

Seaport Therapeutics Initiated at Buy by HC Wainwright & Co.

Seaport Therapeutics, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $50

THOMSON REUTERS

Seaport Therapeutics participates in a conference call with JPMorgan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/SPTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPTX\",,,,,undefined,":{"symbol":"SPTX","market":"US","secType":"STK","nameCN":"Seaport Therapeutics","latestPrice":18.15,"timestamp":1791576000000,"preClose":17.91,"halted":0,"volume":171205,"hourTrading":{"tag":"盘后","latestPrice":18.15,"preClose":18.15,"latestTime":"16:10 EDT","volume":217,"amount":3938.5499999999997,"timestamp":1791576604170,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.013400335008375123,"floatShares":14160000,"shares":53530550,"eps":-2.516,"marketStatus":"Post-Mkt","change":0.24,"latestTime":"10-09 16:38:03 EDT","open":18,"high":18.79,"low":17.89,"amount":3113219,"amplitude":0.050251,"askPrice":21.48,"askSize":160,"bidPrice":17.92,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-2.516,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"listingDate":1777608000000,"exchange":"NASDAQ","adjPreClose":17.91,"postHourTrading":{"tag":"盘后","latestPrice":18.15,"preClose":18.15,"latestTime":"16:10 EDT","volume":217,"amount":3938.5499999999997,"timestamp":1791576604170,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.777532},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPTX\",,,,,undefined,":{"symbol":"SPTX","floatShares":14160000,"roa":"-18.90%","roe":"-28.08%","lyrEps":-10.043037,"volumeRatio":0.777532,"shares":53530550,"dividePrice":0,"high":18.79,"amplitude":0.050251,"preClose":17.91,"low":17.89,"week52Low":14.85,"pbRate":"2.30","week52High":28.3833,"institutionHeld":0,"latestPrice":18.15,"committee":-0.987578,"eps":-2.516,"divideRate":0,"volume":171205,"delay":0,"ttmEps":-2.516,"open":18,"prevYearClose":18,"prevWeekClose":18.42,"prevMonthClose":20.17,"prevQuarterClose":20.17,"fiveDayClose":18.42,"twentyDayClose":23.34,"sixtyDayClose":19.52},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"SPTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.71,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"pre","actualEps":-1.78}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.375,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1790395200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPTX","date":"2026-10-08","current":-7.213831,"percent":0.990741,"low":-14.505892,"twenty":-12.644435,"median":-11.330579,"eighty":-9.343911,"high":-6.903604,"avg":-11.032351,"sd":1.844446,"marketCap":959802761},"quantilePoints":[{"date":"2026-05-08","current":-10.976498,"twenty":-12.440976,"median":-11.330579,"eighty":-11.259763,"marketCap":821931163},{"date":"2026-05-15","current":-11.99625,"twenty":-12.004748,"median":-11.348283,"eighty":-11.231436,"marketCap":898291219},{"date":"2026-05-22","current":-12.173291,"twenty":-12.004748,"median":-11.330579,"eighty":-11.135126,"marketCap":911548174},{"date":"2026-05-29","current":-13.31343,"twenty":-12.537286,"median":-11.684659,"eighty":-11.163453,"marketCap":996922959},{"date":"2026-06-05","current":-12.661922,"twenty":-12.698746,"median":-12.017495,"eighty":-11.247016,"marketCap":948137367},{"date":"2026-06-12","current":-12.548616,"twenty":-12.593938,"median":-12.03874,"eighty":-11.316416,"marketCap":939652917},{"date":"2026-06-18","current":-10.501726,"twenty":-12.6166,"median":-12.03874,"eighty":-11.222938,"marketCap":915372405},{"date":"2026-06-26","current":-11.889673,"twenty":-12.53162,"median":-11.895161,"eighty":-11.165224,"marketCap":1036351448},{"date":"2026-07-02","current":-13.173217,"twenty":-12.752567,"median":-12.017495,"eighty":-11.198861,"marketCap":1148230297},{"date":"2026-07-10","current":-12.595929,"twenty":-12.752567,"median":-12.03874,"eighty":-11.215593,"marketCap":1097911580},{"date":"2026-07-17","current":-11.987935,"twenty":-12.752567,"median":-12.12726,"eighty":-11.302253,"marketCap":1044916336},{"date":"2026-07-24","current":-13.474144,"twenty":-12.866109,"median":-12.187454,"eighty":-11.330579,"marketCap":1174460267},{"date":"2026-07-31","current":-12.479243,"twenty":-12.804736,"median":-12.201617,"eighty":-11.330579,"marketCap":1087740776},{"date":"2026-08-07","current":-14.1804,"twenty":-12.896856,"median":-12.347233,"eighty":-11.365987,"marketCap":1236020399},{"date":"2026-08-14","current":-9.423399,"twenty":-12.896856,"median":-12.221306,"eighty":-11.295171,"marketCap":1269209340},{"date":"2026-08-21","current":-9.552568,"twenty":-12.881452,"median":-12.180373,"eighty":-11.146457,"marketCap":1286606769},{"date":"2026-08-28","current":-10.432907,"twenty":-12.804736,"median":-12.123719,"eighty":-11.036024,"marketCap":1405176937},{"date":"2026-09-04","current":-9.653917,"twenty":-12.782309,"median":-12.017495,"eighty":-10.432907,"marketCap":1300257059},{"date":"2026-09-11","current":-9.252498,"twenty":-12.759648,"median":-11.944292,"eighty":-9.835946,"marketCap":1246191204},{"date":"2026-09-18","current":-8.67223,"twenty":-12.748317,"median":-11.889673,"eighty":-9.660275,"marketCap":1168036601},{"date":"2026-09-25","current":-8.394019,"twenty":-12.694907,"median":-11.667409,"eighty":-9.560914,"marketCap":1130565216},{"date":"2026-10-02","current":-7.531565,"twenty":-12.665919,"median":-11.472211,"eighty":-9.452015,"marketCap":1014403922},{"date":"2026-10-08","current":-7.126172,"twenty":-12.644435,"median":-11.330579,"eighty":-9.343911,"marketCap":959802761}],"updateTime":1791578283654},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666751587","title":"Seaport Therapeutics announces Phase 1 Trial of GlyphAllo met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2666751587","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666751587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:10","pubTimestamp":1788952216,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics (SPTX) announced positive topline results from the Phase 1 Driving Simulation Trial of GlyphAllo, a novel, Glyphed oral prodru...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-announces-phase-1-trial-of-glyphallo-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-announces-phase-1-trial-of-glyphallo-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587398","title":"Seaport Therapeutics Says Phase 1 Trial Shows GlyphAllo 375 Mg Does not Impair Next-Morning Driving vs Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587398","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587398?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:02","pubTimestamp":1788951732,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics says Phase 1 trial shows GlyphAllo 375 mg does not impair next-morning driving vs placeboSeaport Therapeutics reported positive topline Phase 1 driving simulator results for Glyph","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLbv5Xwz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666958209","title":"Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of Glyphallo™ in Healthy Volunteers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666958209","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666958209?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA8RSHWH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666820145","title":"Seaport Therapeutics - Key Secondary Endpoint Met for 250 Mg Glyphallo on Day 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2666820145","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666820145?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA8RSHWH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666758204","title":"Seaport Therapeutics - Enrolling Buoy-1 Phase 2B Trial for Glyphallo; Topline Data Expected First Half 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666758204","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666758204?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA8RSHWH:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582068","title":"Seaport Therapeutics - Glyphallo Well-Tolerated with no Serious Adverse Events Reported","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582068?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA8RSHWH:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582031","title":"Seaport Therapeutics - Phase 1 Trial Meets Primary Endpoint for 375 Mg Glyphallo on Day 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582031","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582031?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA8RSHWH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663707072","title":"Seaport Therapeutics Participates in Citi Biopharma Back to School Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2663707072","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663707072?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:00","pubTimestamp":1788174053,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics participates in Citi Biopharma Back to School conference fireside chatSeaport Therapeutics will attend the 21st Annual Wells Fargo Healthcare Conference on September 8-10, 2026.Management will also join Citi’s 2026 Biopharma Back to School Conference on September 9-10, 2026.A fireside chat is scheduled for September 9, 2026 at 1:00 p.m. ET.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seaport Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on August 31, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL9KvgrM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","IE00BSNM7G36.USD","LU2125154778.USD","BK4585","LU0170899867.USD","SPTX","LU0310800965.SGD","LU0130102774.USD","BK4207","LU1244550494.USD","BK4559","LU0130517989.USD","LU1791807156.HKD","LU0072461881.USD","FTXO","LU0106831901.USD","IYF","TFNS","LU1244550577.SGD","LU1144417596.USD","LU1267930227.SGD","LU2417539215.USD","LU0128525689.USD","BK4566","LU0648001328.SGD","LU2360032135.SGD","BK4588","LU0320765646.SGD","BK4534","LU0980610538.SGD","LU1201861249.SGD","LU2125154935.USD","BK4007","LU2236285917.USD","LU1244550221.USD","LU1506573853.SGD","LU1074936037.SGD","LU0052756011.USD","LU0477156953.USD","LU0203347892.USD","LU0098860793.USD","LU1668664300.SGD","LU2456880835.USD","LU0162691827.USD","LU2462157665.USD","LU0203345920.USD","LU0314106906.USD","LU1162221912.USD","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662743838","title":"Seaport Therapeutics Initiated at Buy by Jones Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2662743838","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662743838?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:26","pubTimestamp":1787757960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SPTX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662158457","title":"JonesTrading Initiates Coverage on Seaport Therapeutics With Buy Rating, $32 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662158457","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662158457?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:22","pubTimestamp":1787743339,"startTime":"0","endTime":"0","summary":"JonesTrading Initiates Coverage on Seaport Therapeutics With Buy Rating, $32 Price Target","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662529997","title":"Wall Street Analysts Are Bullish on Top NA Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2662529997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662529997?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:30","pubTimestamp":1787689822,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Seaport Therapeutics, Inc. (SPTX) and PicS N.V. Class A (PIC...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-na-picks-blurbs-news-24?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-na-picks-blurbs-news-24?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLSG","BLSH","BK4112","OWNB","SPTX","BK4007","BLSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660834682","title":"Seaport Therapeutics Price Target Maintained with a $50.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2660834682","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660834682?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:17","pubTimestamp":1787221020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SPTX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656373765","title":"Seaport Therapeutics Price Target Maintained with a $50.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2656373765","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656373765?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:36","pubTimestamp":1785839760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SPTX/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656783373","title":"Earnings Flash (SPTX) Seaport Therapeutics Posts Q2 Loss $1.78 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2656783373","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656783373?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:11","pubTimestamp":1785755472,"startTime":"0","endTime":"0","summary":"Earnings Flash (SPTX) Seaport Therapeutics Posts Q2 Loss $1.78 a Share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656337346","title":"Seaport Therapeutics Q2 EPS $(1.78) Misses $(0.65) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656337346","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656337346?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:05","pubTimestamp":1785755116,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics (NASDAQ:SPTX) reported quarterly losses of $(1.78) per share which missed the analyst consensus estimate of $(0.65) by 173.85 percent. This is a 72.19 percent increase over losses of $(6.40) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60867629/seaport-therapeutics-q2-eps-1-78-misses-0-65-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656571373","title":"Seaport Therapeutics Q2 FY26 Net Loss Widens to $62.6 Million; R&D Expenses Rise to $24.62 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656571373","media":"Reuters","labels":["executive","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656571373?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:00","pubTimestamp":1785754842,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics Q2 FY26 net loss widens to $62.6 million; R&D expenses rise to $24.62 millionSeaport Therapeutics posted a Q2 2026 net loss of USD 62.6 million, widening from USD 15.1 million a y","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL3pblhQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656543373","title":"Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2656543373","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656543373?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:00","pubTimestamp":1785754801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUA33FR3M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651345211","title":"Seaport Therapeutics Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2651345211","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651345211?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:51","pubTimestamp":1784112660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SPTX/analyst-ratings(END) Dow Jones NewswiresJuly 15, 2026 06:51 ET","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451223","title":"Seaport Therapeutics, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451223?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:04","pubTimestamp":1784109841,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nAZN4T7XXX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651648525","title":"Seaport Therapeutics participates in a conference call with JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2651648525","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651648525?lang=en_us&edition=fundamental","pubTime":"2026-07-15 02:50","pubTimestamp":1784055022,"startTime":"0","endTime":"0","summary":"JPMorgan holds a conference call with management on July 14 at 3 pm. Webcast Link Published first on TheFly – the ultimate source for real-time, ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-participates-in-a-conference-call-with-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-participates-in-a-conference-call-with-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2430703095.HKD","KBWB","LU2552382058.USD","LU2505996681.GBP","JPMO","LU0859254822.USD","LU1496350171.SGD","LU1988902786.USD","LU0417517546.SGD","LU0234572021.USD","JPO","LU1116320901.HKD","LU0310799852.SGD","LU2211815571.USD","LU2106854487.HKD","IYG","FTXO","SPTX","LU2357627491.SGD","LU1363072403.SGD","SG9999002224.SGD","IYF","IE00BJTD4N35.SGD","LU1548497426.USD","LU2237443622.USD","LU2242649171.HKD","LU1670628061.USD","FNCL","BK4516","XLF","LU1551013425.SGD","JPM","IE0034235188.USD","IXG","LU1720051108.HKD","IE00BN8TJ469.HKD","VFH","LU2054465674.USD","IE00BYXW3230.USD","LU0238689110.USD","UYG","LU0149725797.USD","IE00B1BXHZ80.USD","LU0211328371.USD","LU2381873111.SGD","IE00B775SV38.USD","JPX","LU2236285917.USD","LU1116320737.USD","PGF"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":73,"code":"91000000","status":"200"}]}}